D. Mark McClung
2021
Compensation breakdown
| Non-Equity Incentive Plan | $184,734 |
|---|---|
| Option Awards | $591,728 |
| Salary | $427,673 |
| Stock Awards | $447,600 |
| Other | $5,554 |
| Total | $1,657,289 |
McClung received $591.7K in option awards, accounting for 36% of the total pay in 2021.
McClung also received $184.7K in non-equity incentive plan, $427.7K in salary, $447.6K in stock awards and $5.6K in other compensation.
Rankings
In 2021, D. Mark McClung's compensation ranked 6,820th out of 12,405 executives tracked by ExecPay. In other words, McClung earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,820 out of 12,405 | 45th |
Division Manufacturing | 2,966 out of 5,494 | 46th |
Major group Chemicals And Allied Products | 1,314 out of 2,369 | 45th |
Industry group Drugs | 1,172 out of 2,090 | 44th |
Industry Biological Products, Except Diagnostic Substances | 279 out of 452 | 38th |
Pay ratio
| D. Mark McClung's Pay | $1,657,289 |
|---|---|
| Median Employee's Pay | $170,218 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of D. Mark McClung was $1,657,289.
The annual total compensation of the median employee at Sangamo Biosciences was $170,218.
The ratio of D. Mark McClung's pay to the pay of median employee was therefore 10 to one.
McClung's colleagues
We found five more compensation records of executives who worked with D. Mark McClung at Sangamo Biosciences in 2021.
2021
Alexander Macrae
Sangamo Biosciences
Chief Executive Officer
2021
Robert Schott
Sangamo Biosciences
Senior Vice President, Head of Development
2021
R Ramelmeier
Sangamo Biosciences
Executive Vice President, Technical Operations
2021
Prathyusha Duraibabu
Sangamo Biosciences
Chief Financial Officer
2021
Sung Lee
Sangamo Biosciences